Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
4.83 %
$ 346 M
Market Cap
-0.88
P/E
AMLX - LONG-TERM DEBT
Long-term Debt AMLX - Amylyx Pharmaceuticals, Inc.
463 K
LAST VALUE
-66.94%
2 YEAR CAGR
-50.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR